← Leaderboards
Travis Blum
Broad Institute, Inc.
$179,478
Attributed
$179,478
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $63.7K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$179,478 · 1
By mechanism
F32$179,478 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$247,762,266
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$211,662,224
Research focus
BaseBacteriophagesBiochemicalBiological ProductsBinding SitesBiomacromoleculeBontoxilysinBotulinum Toxin Type ABreast Cancer Cell LineCatalystBiological SystemsChemistryCholinergic NeuronCleaved CellCommunitiesCytoplasmCytosolDrug ResistanceEngineeringEnzymesEventEvolutionExtracellularFamily Member
Grant awards (3)
REPROGRAMMING BOTULINUM NEUROTOXIN PROTEASES THROUGH CONTINUOUSEVOLUTION AS A STRATEGY FOR DEVELOPING SELECTIVE INTRACELLULAR THERAPIES$63,746
F32 · FY2019 · GM · contact PI
REPROGRAMMING BOTULINUM NEUROTOXIN PROTEASES THROUGH CONTINUOUSEVOLUTION AS A STRATEGY FOR DEVELOPING SELECTIVE INTRACELLULAR THERAPIES$59,038
F32 · FY2018 · GM · contact PI
REPROGRAMMING BOTULINUM NEUROTOXIN PROTEASES THROUGH CONTINUOUSEVOLUTION AS A STRATEGY FOR DEVELOPING SELECTIVE INTRACELLULAR THERAPIES$56,694
F32 · FY2017 · GM · contact PI